Cephalexin is NOT recommended as first-line therapy for osteomyelitis
Cephalexin should not be used for osteomyelitis treatment. The available guidelines and evidence do not support cephalexin as an appropriate antibiotic choice for bone infections, and first-generation cephalosporins like cephalexin are specifically noted to be inactive against key osteomyelitis pathogens.
Why Cephalexin is Inappropriate for Osteomyelitis
Guideline Evidence Against Cephalexin
The IDSA guidelines for MRSA osteomyelitis 1, 2, 1 do not include cephalexin among recommended antibiotics. For MRSA osteomyelitis, recommended options include:
- Parenteral: IV vancomycin or daptomycin 6 mg/kg/dose daily
- Oral options: TMP-SMX 4 mg/kg/dose twice daily (with rifampin), linezolid 600 mg twice daily, or clindamycin 600 mg every 8 hours
For MSSA skin and soft tissue infections, the IDSA guidelines 3, 4, 5 list cephalexin at 500 mg four times daily (adults) or 25-50 mg/kg/day in 4 divided doses (children) - but these are explicitly for skin infections, not bone infections.
Critical Limitation: Spectrum of Activity
First-generation cephalosporins like cephalexin are inactive against many osteomyelitis pathogens. The Lyme disease guidelines 6 explicitly state: "first-generation cephalosporins, such as cephalexin, are inactive in vitro against B. burgdorferi and are ineffective clinically."
Appropriate Antibiotics for Osteomyelitis
For MSSA Osteomyelitis (if susceptible organism confirmed):
Adults:
- Nafcillin or oxacillin: 1-2 g IV every 4 hours 3, 4
- Cefazolin: 1 g IV every 8 hours (for penicillin-allergic patients)
- Oral step-down options (after initial IV therapy): Dicloxacillin 500 mg four times daily
Children:
- Nafcillin or oxacillin: 100-150 mg/kg/day IV in 4 divided doses 3, 4
- Cefazolin: 50 mg/kg/day IV in 3 divided doses
For MRSA Osteomyelitis:
- Vancomycin: 15-20 mg/kg/dose IV every 8-12 hours (adults); 15 mg/kg/dose every 6 hours (children)
- Target trough 15-20 mcg/mL for serious infections
- Daptomycin: 6 mg/kg/dose IV once daily (some experts use 8-10 mg/kg)
Oral options (after clinical stability achieved) 1, 2:
- TMP-SMX: 4 mg/kg/dose (TMP component) twice daily + rifampin 600 mg daily
- Linezolid: 600 mg twice daily (adults); 10 mg/kg every 8 hours for children <12 years
- Clindamycin: 600 mg every 8 hours (if susceptible)
Duration of Therapy
Minimum 8 weeks total antibiotic therapy is recommended 1, 2, 1. The 2022 WikiGuidelines consensus 7 supports up to 6 weeks for osteomyelitis without retained implants, assuming adequate source control.
Renal Dose Adjustment
Since cephalexin is renally cleared 8, 9, if it were to be used (which it should not be for osteomyelitis):
- CrCl <30 mL/min: Reduce dose proportionally to reduced renal function
- Standard adult dose: 1-4 g daily in divided doses 8
- Pediatric dose: 25-50 mg/kg/day in divided doses 8
Recent Research Context
While recent studies 10, 11, 12 have explored cephalexin for MSSA bone and joint infections in specific contexts (particularly as oral step-down therapy after prolonged IV treatment), these represent emerging data not yet incorporated into major guidelines. One study 10 showed 87% success with cephalexin 1,500-2,000 mg/day for completing treatment of MSSA vertebral osteomyelitis, but only after at least 3 weeks of effective IV therapy first.
Clinical Algorithm
- Obtain cultures before starting antibiotics
- Start empiric IV therapy based on likely pathogen (vancomycin for MRSA coverage)
- Ensure source control: surgical debridement if indicated 1, 2
- Narrow therapy based on culture results
- Consider oral step-down only after clinical stability (typically 2-4 weeks IV minimum)
- Complete 6-8 weeks total antibiotic therapy
Do not use cephalexin as primary therapy for osteomyelitis. Use anti-staphylococcal penicillins, cefazolin, or MRSA-active agents as outlined above.